Results 51 to 60 of about 3,282 (184)

Higher dose of palonosetron versus lower dose of palonosetron plus droperidol to prevent postoperative nausea and vomiting after eye enucleation and orbital hydroxyapatite implant surgery: a randomized, double-blind trial

Drug Design, Development and Therapy, 2017
Xiao Hu, Fang Tan, Lan Gong Department of Anesthesiology, The Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai Medical College of Fudan University, Shanghai, China Objective: Postoperative nausea and vomiting (PONV) is ...
Hu X, Tan F, Gong L
doaj  

Fixed combination of oral NEPA (netupitant‐palonosetron) for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double‐blind phase III studies

Cancer Medicine, 2019
Aim To assess the efficacy of oral NEPA (netupitant‐palonosetron 300/0.50 mg) over multiple chemotherapy cycles. Methods Two randomized phase III studies evaluated a single dose of oral NEPA given on day 1 in chemotherapy‐naive patients receiving ...
Lee Schwartzberg, Meinolf Karthaus, Giorgia Rossi, Giada Rizzi, Maria E. Borroni, Hope S. Rugo, Karin Jordan, Vincent Hansen   +7 more
doaj   +1 more source

Efficacy of single dose NEPA, a fixed combination of netupitant and palonosetron, versus a 3-day regimen of aprepitant/granisetron (APR/GRAN) for prevention of nausea in patients receiving high dose cisplatin [PDF]

, 2018
Arunee Dechaphunkul, Shun Lü, Silvia Olivari, L. Zhang   +3 more
openalex   +1 more source

4CPS-006 Evaluation study of the change in administration timing of fixed combination: netupitant and palonosetron in oncohaematologic patients with high doses of carboplatin [PDF]

, 2022
Marta Albanell‐Fernández, Gisela Riu-Viladoms, Inés Monge‐Escartín, M. Alsina Rodríguez, Alexis Perez, ML Corominas, A Escolà, Natàlia Arranz, Ronald Ramon, Dolors Soy, Esther Carcelero   +10 more
openalex   +1 more source

Dexamethasone-sparing regimens with NEPA (netupitant/palonosetron) for the prevention of chemotherapy-induced nausea and vomiting in older patients (>65 years) fit for cisplatin: A sub-analysis from a phase 3 study [PDF]

, 2023
Luigi Celio, Rupert Bartsch, Matti Aapro
openalex   +1 more source

Palonosetron in the management of chemotherapy- induced nausea and vomiting in patients receiving multiple-day chemotherapy

Cancer Management and Research, 2014
Mary Lou Affronti,1 Joseph Bubalo2 1Duke University Medical Center, Durham, NC, 2Oregon Health and Science University Hospital and Clinics, Portland, OR, USA Abstract: Prevention of chemotherapy-induced nausea and vomiting (CINV) is a key component of ...
Affronti ML, Bubalo J
doaj  

Palonosetron on Days 1 and 5 Versus Granisetron Daily (Days 1-5) in Germ Cell Tumour Therapy [PDF]

, 2019
Yusuke Shimura, Kouji Izumi, Shingo Itai, Hiroaki Iwamoto, Hiroshi Yaegashi, Yukio Suga, Tsutomu Shimada, Atsushi Mizokami, Yoshimichi Sai   +8 more
openalex   +1 more source

Comparison of Palonosetron with Ondansetron in Prevention of Postspinal Shivering: A Randomised Controlled Trial

Journal of Clinical and Diagnostic Research
Introduction: Postspinal shivering is a frequent and distressing complication following spinal anaesthesia due to impaired thermoregulation that leads to redistribution of body heat, resulting in hypothermia, increased metabolic demand, and patient ...
Sai Hrudaya Harshitha Akondi, Rajagopalan Venkatraman, Karthika Urkavalan   +2 more
doaj   +1 more source

Effect of pretreatment with palonosetron on withdrawal movement associated with rocuronium injection [PDF]

, 2014
Kwangrae Cho, Seoung Hun Lee, Wonjin Lee, Byung-Kwan Chu, Myoung-Hun Kim, Se Hun Lim, Kun Moo Lee   +6 more
openalex   +1 more source

Comparison of IV granisetron and IV palonosetron on hemodynamics and sensory and motor block after spinal anesthesia with hyperbaric bupivacaine in patients undergoing abdominal hysterectomy

, 2019
Rajesh Mahajan, Jasmeen Choudhary, Arti Mahajan, Smriti Gulati, Anjali Mehta, Robina Nazir   +5 more
openalex   +1 more source